Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage

Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)

NCT03569293 ·Status: COMPLETED ·Phase: PHASE3

Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis

NCT05456529 ·Status: COMPLETED ·Phase: PHASE3

A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis

NCT07193589 ·Status: RECRUITING ·Phase: PHASE2

Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients

NCT00523952 ·Status: COMPLETED ·Phase: PHASE3

Apremilast for Atopic Dermatitis - A Pilot Study in Adults

NCT01393158 ·Status: COMPLETED ·Phase: PHASE2

Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

NCT03989349 ·Status: COMPLETED ·Phase: PHASE3

Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis

NCT03091426 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis

NCT02347176 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Safety & Efficacy of Topical ATx201 OINTMENT in Adolescents and Adults With Mild to Moderate AD

NCT04339985 ·Status: COMPLETED ·Phase: PHASE2

Study of 0417 Ointment in the Treatment of Atopic Dermatitis

NCT01139450 ·Status: COMPLETED ·Phase: PHASE3

A Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic Dermatitis

NCT03920852 ·Status: COMPLETED ·Phase: PHASE1

A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis

NCT06119529 ·Status: TERMINATED ·Phase: PHASE1

Effect of OC000459 on Moderate to Severe Atopic Dermatitis

NCT02002208 ·Status: COMPLETED ·Phase: PHASE2

Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials

NCT05492578 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3

Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

NCT03989206 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

NCT06241118 ·Status: RECRUITING ·Phase: PHASE3

Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis

NCT00117377 ·Status: COMPLETED ·Phase: PHASE4

Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis

NCT00376129 ·Status: COMPLETED ·Phase: PHASE2

Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis

NCT05990725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

NCT03952559 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis

NCT02795832 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.

NCT04836858 ·Status: COMPLETED ·Phase: PHASE2

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

NCT06988605 ·Status: RECRUITING

Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

NCT01568489 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

NCT03985943 ·Status: COMPLETED ·Phase: PHASE3